CD19 for Modern CAR-T Workflows

On this page

Transcript

Modern CAR-T workflows depend on CD19 that preserves its native ectodomain structure and has reliable high-affinity binding.

  • CAR expression detection
  • scFv generation and screening
  • CAR-T development assays

Conigen’s mammalian-expressed CD19 dimers use a short, proprietary linker to stabilize the cis-dimer ectodomain driving superior binding affinity and a wider assay window.

These Fc-free, high-fidelity dimers outperform monomers and are available in human, mouse, and non-human primate versions, including biotinylated Avi-tag and custom variants. Start your next discovery with Conigen’s CD19.